Our hypothesis is that this may be related to downregulation of EGFR in CRC tumors as interrogating the CPTAC dataset showed significant KRAS mutation‐independent downregulation of EGFR in the tumors compared to the matched mucosa (n = 96 pairs; P < 0.0001). The gene discussed is EGFR; the disease is colorectal carcinoma.